Teladoc Health (NYSE:TDOC - Free Report) had its price target upped by Bank of America from $11.50 to $13.50 in a research note published on Wednesday,Benzinga reports. They currently have a neutral rating on the health services provider's stock.
Other equities analysts have also issued research reports about the company. Deutsche Bank Aktiengesellschaft upped their price target on Teladoc Health from $10.00 to $12.00 and gave the company a "hold" rating in a research note on Friday, November 1st. Oppenheimer cut their price target on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a report on Friday, January 24th. Barclays upped their price target on Teladoc Health from $10.00 to $12.00 and gave the stock an "overweight" rating in a report on Thursday, October 31st. Piper Sandler reaffirmed an "overweight" rating and set a $13.00 price objective (up from $11.00) on shares of Teladoc Health in a research report on Wednesday, December 4th. Finally, The Goldman Sachs Group assumed coverage on Teladoc Health in a research report on Friday, November 15th. They set a "buy" rating and a $14.00 price objective for the company. Fourteen investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, Teladoc Health presently has a consensus rating of "Hold" and a consensus price target of $12.08.
Check Out Our Latest Research Report on Teladoc Health
Teladoc Health Trading Up 6.3 %
NYSE TDOC traded up $0.85 on Wednesday, reaching $14.36. 20,718,368 shares of the company were exchanged, compared to its average volume of 4,791,036. The business's fifty day moving average price is $10.28 and its 200 day moving average price is $9.28. The stock has a market capitalization of $2.47 billion, a P/E ratio of -2.49 and a beta of 1.05. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health has a fifty-two week low of $6.76 and a fifty-two week high of $21.74.
Insider Buying and Selling at Teladoc Health
In other news, insider Carlos Nueno sold 2,389 shares of the business's stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the transaction, the insider now directly owns 2,890 shares in the company, valued at approximately $34,477.70. The trade was a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.95% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Teladoc Health
A number of institutional investors have recently added to or reduced their stakes in TDOC. Versant Capital Management Inc lifted its position in Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after purchasing an additional 2,441 shares during the period. Whipplewood Advisors LLC acquired a new stake in Teladoc Health in the fourth quarter worth approximately $29,000. Lindbrook Capital LLC lifted its position in Teladoc Health by 78.9% in the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after purchasing an additional 1,612 shares during the period. Blue Trust Inc. lifted its position in Teladoc Health by 84.5% in the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider's stock worth $40,000 after purchasing an additional 1,854 shares during the period. Finally, Sterling Capital Management LLC lifted its position in Teladoc Health by 776.7% in the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock worth $42,000 after purchasing an additional 4,101 shares during the period. 76.82% of the stock is currently owned by institutional investors and hedge funds.
Teladoc Health Company Profile
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
See Also

Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.